Cita APA (7a ed.)
Chan, S., Hu, M., Ko, S., Tam, C., Fok, B., Yin, O., . . . Tomlinson, B. (2013). CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects. European Journal of Clinical Pharmacology, 69(4), 799-807.
Cita Chicago Style (17a ed.)
Chan, Sze, Miao Hu, Sara Ko, Catherine Tam, Benny Fok, Ophelia Yin, Moses Chow, y Brian Tomlinson. "CYP2C19 Genotype Has a Major Influence on Labetalol Pharmacokinetics in Healthy Male Chinese Subjects." European Journal of Clinical Pharmacology 69, no. 4 (2013): 799-807.
Cita MLA (9a ed.)
Chan, Sze, et al. "CYP2C19 Genotype Has a Major Influence on Labetalol Pharmacokinetics in Healthy Male Chinese Subjects." European Journal of Clinical Pharmacology, vol. 69, no. 4, 2013, pp. 799-807.
Precaución: Estas citas no son 100% exactas.